Navigation Links
Publishers John Wiley & Sons Enter Into An Agreement With NASPGHAN And AASLD

Global publisher John Wiley & Sons, Inc., confirms their plans to go into a partnership with NASPGHAN and AASLD for providing subscriptions of their journal.//

International publisher John Wiley & Sons, Inc., had announced on the 6th of September their plans of a new agreement with the North American Society for Paediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the American Association for the Study of Liver Diseases (AASLD).

Announcing that under this agreement they would provide complimentary subscriptions of the journal Hepatology to all NASPGHAN fellows, they explained that Wiley & Co publishes ‘Hepatology’, which is the official journal of AASLD on behalf of the Association. The journal is one of the leading worldwide journals that publish original, peer-reviewed articles pertaining to all aspects of liver, its structure, function, and disease.

“As chair of the AASLD Publications Committee, I am pleased that our publisher, John Wiley & Sons, Inc. is providing Hepatology without charge to trainees in Paediatric Gastroenterology/Hepatology,” said William Balistreri, M.D. “Hepatology is the premier journal in the field and access to the important basic and translational research published in its pages will stimulate young investigators and we hope lead to the improved care of children with hepatobiliary disease.”

"NASPGHAN welcomes this partnership with AASLD and Wiley and appreciates the generous support extended to the training and educating of our next generation of paediatric gastroenterologist," said Philip M. Sherman, M.D., and President of NASPGHAN.

Source-EurekalertVIK
'"/>




Page: 1

Related medicine news :

1. More Doctors Suspended As Strike Enters Seventh Day
2. Doctors Strike In Andhra Enters The Second Day
3. Anti-Quota Stir: Stalemate Continues; Fast Enters 10th Day
4. Bird Flu Virus Entered New Zealand
5. AIIMS Strike Enters Second day, Support Continues To Pour In
6. JIPMER Strike Enters Eighth Day
7. Enbrelr Enters Safer Zone After Recent Research
8. Most Of The Ear Infections Entertain Both Bacteria And Viruses
9. The Food Pyramid Guide Enters Supermarkets
10. Pharma Major Ind-Swift to Enter US, Japan
11. Vandetanib Study Enters Third Phase

Post Your Comments:
(Date:12/3/2009)... Calif., Dec. 3 The Boa...al Studies unanimously voted to elect three new m..., Fred Dotzler is co-founder and Managing Direc...vo is investing $650 million from three funds in e...ies. Dotzler founded Medicus Venture Partners in 1...
(Date:12/3/2009)...A, Calif., Dec. 3 For California,s...sk of disability remains one of the most significa...ll being, but also their business,s viability. ,...en their toll, owners of small businesses are reco...y net with enhanced disability coverage," said Mi...
(Date:12/3/2009)... Fla., Dec. 3 If you have seen "Su... for a stunning look at the other side of the dini... screen her feature documentary, "Supercharge Me! ...ember 8th, 5 p.m. at Sever Hall, Harvard Yard. The...College Tour. The film will be followed by a lectu...
(Date:12/3/2009)..., Pa., Dec. 3 Southern Tier Health...are Inc. (ICW), a global leader in eHealth technol...nents for its Health Information Exchange (HIE). ...ndex (EMPI), Enterprise Master Provider Registry (...ties, 470,000 residents, 8 hospitals, and over 800...
(Date:12/3/2009)... Harmful procedures on young women caused by outd...ch sues FDA on December 11 for blocking new techno...EB) December 2, 2009 -- Now the American College ...hat the invasive cancer workup procedure, also kno...nnecessary to some women who have received the pro...
Breaking Medicine News(10 mins):Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2Health News:Southern Tier HealthLink NY Selects InterComponentWare to Deliver Core Components of HIE 2Health News:Harmful Procedures on Young Women Caused by Outdated HPV test, not by Pap Test 2
...n of Leading Calcium Brand Enriches Consumer Care ...oduct Portfolio, MORRISTOWN, N.J., Oct. 5 Bayer ... Care Division has received regulatory,approvals n...Mission Pharmacal was closed yesterday evening at ...
...POLIS, Oct. 5 Eli Lilly and Company,announced tod... U.S. Food,and Drug Administration (FDA), the comp...mbyax(R) (olanzapine and fluoxetine HCl) U.S. prod...ed pooled analyses of Lilly,s,clinical trial data ...
..., Oct. 5 Cell Therapeutics, Inc. (CTI),(Nasdaq: ...hnology Industry,Organization (BIO) Investor Forum...-11, 2007, at the Palace Hotel in,San Francisco. C...tation. The webcast can be accessed at, http://www...
...AN FRANCISCO, Calif., Oct. 5 Anesiva,Inc. (Nasdaq... the company,s,chief executive officer, will prese...IO InvestorForum 2007" on Thursday, October 11, 20... Investors page, and click on,Events. Please conne...
...Oct. 5 Any well-informed parent knows about the,F...ith cold & flu season,upon us, parents scramble to...gestion. Nosefrida nasal aspirator -- a Swedish pr...ar medicines such as Dimetapp and Triaminic,rarely...
...ent, Health, NGOs, Sports, Academic, and Business ...l-being of Individuals with Intellectual ..., Oct. 5 /Xinhua-PRNewswire-USNewswire/ -- Leaders...pecial Olympics World Summer Games in Shanghai, Ch...
Other Medicine News:Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 2Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 3Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 2Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 3Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 4Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 5Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 6Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 7Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 8Health News:Nosefrida Nasal Aspirator - A Parent's Alternative to Medicines on the Verge of FDA Ban 2Health News:Global Leaders Converge for Special Olympics Global Policy Summit 2Health News:Global Leaders Converge for Special Olympics Global Policy Summit 3Health News:Global Leaders Converge for Special Olympics Global Policy Summit 4
(Date:12/3/2009)... , , PISCATAWAY, N.J., Dec. 3 /PRNew... Bulletin Board: MLSS), the recognized leader in a...at it had entered into a joint venture with China ...arm") and Yichang Humanwell Pharmaceutical Co. Ltd...hina (the "PRC"), to develop orthopedic and epidur...
(Date:12/3/2009)... , , MAPLE GROVE, Minn., Dec. 3 /PRNe...nnounced the next phase of its strategic plan for ...(extended release topiramate), an internally devel...5 is being developed with Upsher-Smith,s proprieta...II clinical trial in early 2010 for the adjunctive...
(Date:12/3/2009)... , , ROCHESTER, N.Y., Dec. 3 /PRNewswire-F...), a leading provider of quantitative imaging for ...itled "System and Method for 4D Reconstruction and...n. ,, VirtualScopics, Vice President of Technol...ated, "We are pleased that Japan has recognized th...
Breaking Medicine Technology:Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Upsher-Smith Announces Milestone in Development of CNS Strategy 2VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3HealthFitness President Gregg O Lehman Named to DMAA Board of Directors 58047 1HealthFitness President Gregg O Lehman Named to DMAA Board of Directors 58047 2Small Steps May Speed Recovery in ICU Patients 58045 1Small Steps May Speed Recovery in ICU Patients 58045 2Hormone Therapy for Prostate Cancer Raises Heart Risks 58043 1Hormone Therapy for Prostate Cancer Raises Heart Risks 58043 2
...mprovement in Personal and Social,Performance,...re/ --,Longer-term treatment with INVEGA(TM) (pa... daily oral medication for,schizophrenia, helped...s and maintain their improvements in personal and ...om a large, open label, international,clinical t...
...WIRE)--Mar 30, 2007 - NEOPHARM, Inc.,(Nasdaq: NEOL...trial in second-line metastatic colorectal cancer ...the active metabolite of irinotecan,(Camptosar(R))...,completion of treatment of the first 21 patients ...not achieve the primary tumor,response endpoint. N...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6NeoPharm Provides Update on LE-SN38 Program 2
Castroviejo Double Ended Lacrimal Dilator
Wheeler Cyclodialysis Spatula
Thornton Phacoemulsification Spatula
Culler Iris Spatula
Medicine Products: